Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density
- PMID: 11771656
- DOI: 10.1359/jbmr.2002.17.1.11
Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density
Comment in
-
Potential impact of osteoporosis treatment on hip fracture trends.J Bone Miner Res. 2005 Jun;20(6):895-7. doi: 10.1359/JBMR.050308. Epub 2005 Mar 7. J Bone Miner Res. 2005. PMID: 15883627 No abstract available.
Comment on
-
Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy.J Bone Miner Res. 2002 Jan;17(1):1-10. doi: 10.1359/jbmr.2002.17.1.1. J Bone Miner Res. 2002. PMID: 11771654 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical